Michl P - Search Results

1

Stromal biology and therapy in pancreatic cancer.

Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, Tuveson DA. Neesse A, et al. Among authors: michl p. Gut. 2011 Jun;60(6):861-8. doi: 10.1136/gut.2010.226092. Epub 2010 Oct 21. Gut. 2011. PMID: 20966025 Review.

2

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.

Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM. Weber CK, et al. Among authors: michl p. Gastroenterology. 2001 Sep;121(3):657-67. doi: 10.1053/gast.2001.27222. Gastroenterology. 2001. PMID: 11522750

3

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

Michl P, Buchholz M, Rolke M, Kunsch S, Löhr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. Michl P, et al. Gastroenterology. 2001 Sep;121(3):678-84. doi: 10.1053/gast.2001.27124. Gastroenterology. 2001. PMID: 11522752

4

Use of DNA arrays/microarrays in pancreatic research.

Buchholz M, Boeck W, Fensterer H, Müller F, Wenger C, Michl P, Adler G, Gress TM. Buchholz M, et al. Among authors: michl p. Pancreatology. 2001;1(6):581-6. doi: 10.1159/000055867. Pancreatology. 2001. PMID: 12120240 Review.

5

Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.

Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, Leder G, Iwamura T, Adler G, Gress TM. Michl P, et al. Cancer Res. 2003 Oct 1;63(19):6265-71. Cancer Res. 2003. PMID: 14559813

6

Bacteria and bacterial toxins as therapeutic agents for solid tumors.

Michl P, Gress TM. Michl P, et al. Curr Cancer Drug Targets. 2004 Dec;4(8):689-702. doi: 10.2174/1568009043332727. Curr Cancer Drug Targets. 2004. PMID: 15578923 Review.

7

CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.

Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, Poulsom R, D'Arrigo C, Ryder K, Menke A, Gress T, Downward J. Michl P, et al. Cancer Cell. 2005 Jun;7(6):521-32. doi: 10.1016/j.ccr.2005.05.018. Cancer Cell. 2005. PMID: 15950902 Free article.

8

Evidence-based diagnosis and staging of pancreatic cancer.

Michl P, Pauls S, Gress TM. Michl P, et al. Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):227-51. doi: 10.1016/j.bpg.2005.10.005. Best Pract Res Clin Gastroenterol. 2006. PMID: 16549326 Review.

9

Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V. Buchholz M, et al. Among authors: michl p. EMBO J. 2006 Aug 9;25(15):3714-24. doi: 10.1038/sj.emboj.7601246. Epub 2006 Jul 27. EMBO J. 2006. PMID: 16874304 Free PMC article.

10

WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.

Ripka S, König A, Buchholz M, Wagner M, Sipos B, Klöppel G, Downward J, Gress T, Michl P. Ripka S, et al. Among authors: michl p. Carcinogenesis. 2007 Jun;28(6):1178-87. doi: 10.1093/carcin/bgl255. Epub 2007 Jan 16. Carcinogenesis. 2007. PMID: 17227781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page